Boule Diagnostics AB (publ) (STO:BOUL)
Sweden
· Delayed Price · Currency is SEK 3.870
+0.050 (1.31%)
Apr 29, 2026, 10:39 AM CET
Boule Diagnostics AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 489.69 | 558.46 | 571.33 | 548.09 | 463.34 | Upgrade
|
| Revenue Growth (YoY) | -12.31% | -2.25% | 4.24% | 18.29% | 15.70% | Upgrade
|
| Cost of Revenue | 275.88 | 303.33 | 321.62 | 320.18 | 264.71 | Upgrade
|
| Gross Profit | 213.81 | 255.13 | 249.71 | 227.91 | 198.64 | Upgrade
|
| Selling, General & Admin | 129.64 | 146.89 | 153.35 | 143.6 | 120.15 | Upgrade
|
| Research & Development | 40.4 | 37.8 | 53.09 | 51.57 | 43.33 | Upgrade
|
| Other Operating Expenses | -2.44 | 6.62 | - | -0.74 | -0.7 | Upgrade
|
| Operating Expenses | 167.6 | 191.31 | 206.44 | 194.43 | 162.78 | Upgrade
|
| Operating Income | 46.21 | 63.82 | 43.27 | 33.48 | 35.86 | Upgrade
|
| Interest Expense | -15.88 | -12.49 | -11.3 | -9.85 | -5.49 | Upgrade
|
| Interest & Investment Income | 1.52 | 1.39 | 1.14 | 1.78 | 1.35 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.15 | 0.15 | -3.01 | -4.5 | -2.95 | Upgrade
|
| Other Non Operating Income (Expenses) | - | -0.1 | 0 | -0 | -0 | Upgrade
|
| EBT Excluding Unusual Items | 31.7 | 52.77 | 30.1 | 20.9 | 28.77 | Upgrade
|
| Merger & Restructuring Charges | -18.47 | -22.8 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.4 | - | - | -0.05 | - | Upgrade
|
| Asset Writedown | -6.92 | -390.72 | - | - | - | Upgrade
|
| Pretax Income | 5.91 | -360.75 | 30.1 | 20.85 | 28.77 | Upgrade
|
| Income Tax Expense | 9.66 | -64.17 | 5.12 | 8.12 | 5.5 | Upgrade
|
| Net Income | -3.75 | -296.58 | 24.98 | 12.73 | 23.27 | Upgrade
|
| Net Income to Common | -3.75 | -296.58 | 24.98 | 12.73 | 23.27 | Upgrade
|
| Net Income Growth | - | - | 96.24% | -45.31% | - | Upgrade
|
| Shares Outstanding (Basic) | 39 | 39 | 39 | 28 | 27 | Upgrade
|
| Shares Outstanding (Diluted) | 39 | 39 | 39 | 28 | 27 | Upgrade
|
| Shares Change (YoY) | - | - | 36.37% | 4.65% | 40.14% | Upgrade
|
| EPS (Basic) | -0.10 | -7.64 | 0.64 | 0.46 | 0.87 | Upgrade
|
| EPS (Diluted) | -0.10 | -7.64 | 0.64 | 0.45 | 0.86 | Upgrade
|
| EPS Growth | - | - | 42.22% | -47.67% | - | Upgrade
|
| Free Cash Flow | -2.66 | 37.68 | 44.51 | -17.79 | 40.14 | Upgrade
|
| Free Cash Flow Per Share | -0.07 | 0.97 | 1.15 | -0.63 | 1.48 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.550 | Upgrade
|
| Gross Margin | 43.66% | 45.68% | 43.71% | 41.58% | 42.87% | Upgrade
|
| Operating Margin | 9.44% | 11.43% | 7.57% | 6.11% | 7.74% | Upgrade
|
| Profit Margin | -0.77% | -53.11% | 4.37% | 2.32% | 5.02% | Upgrade
|
| Free Cash Flow Margin | -0.54% | 6.75% | 7.79% | -3.25% | 8.66% | Upgrade
|
| EBITDA | 49.95 | 67.98 | 60.41 | 54.14 | 51.17 | Upgrade
|
| EBITDA Margin | 10.20% | 12.17% | 10.57% | 9.88% | 11.04% | Upgrade
|
| D&A For EBITDA | 3.74 | 4.16 | 17.14 | 20.66 | 15.31 | Upgrade
|
| EBIT | 46.21 | 63.82 | 43.27 | 33.48 | 35.86 | Upgrade
|
| EBIT Margin | 9.44% | 11.43% | 7.57% | 6.11% | 7.74% | Upgrade
|
| Effective Tax Rate | 163.49% | - | 17.02% | 38.95% | 19.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.